The lysosomal hexosaminidase isozymes.

Area of Science:

• Biochemistry
• Molecular Biology
• Genetics

Background:

• The enzyme Hexosaminidase A (HEX A) is known to be defective in Tay-Sachs disease (TSD).
• Previous understanding recognized two HEX isozymes, but current research identifies multiple species arising from at least three genes.

Purpose of the Study:

• To elucidate the diversity of HEX enzyme species and their roles in human tissues and fluids.
• To investigate the biosynthesis, glycosylation, and structural heterogeneity of HEX enzymes.
• To explore the relationship between HEX enzyme defects and clinical phenotypes of GM2 gangliosidosis.

Main Methods:

• Biochemical characterization of HEX enzyme species from human tissues and fluids.
• Analysis of polypeptide processing and glycosylation patterns.
• Isoelectric focusing to study enzyme microheterogeneity.
• Investigation of HEX enzyme activity and activator protein function.

Main Results:

• Identified multiple HEX species, including HEX A, HEX B, and HEX D, with distinct alpha and beta polypeptide subunits.
• Demonstrated that serum HEX A (HEX AS) is a precursor form compared to lysosomal HEX A.
• Revealed differences in glycosylation between lysosomal and serum HEX species.
• Observed microheterogeneity in HEX B and described differences between beta subunit chains.
• Highlighted the role of a protein activator for HEX A activity and linked its deficiency to GM2 gangliosidosis.

Conclusions:

• The HEX enzyme family is more complex than previously thought, with multiple gene products and processing pathways.
• Variations in HEX enzyme species, glycosylation, and structure contribute to different clinical presentations of TSD and related storage diseases.
• Further molecular characterization of HEX gene defects is needed to fully understand the spectrum of GM2 gangliosidosis phenotypes.